Florian Klein receives DZIF Prize for translational infection research
Prof Florian Klein`s main goal is to improve HIV therapy with the help of antibodies and to develop a HIV vaccine. His research was now honoured with the DZIF Prize for translational research. Prof Ulrike Protzer, DZIF Executive Board, presented the award.
European survey on antibiotic resistance in hospitals
An international team of scientists and clinicians have, for the first time, examined the spread of particularly dreaded multidrug-resistant Enterobacteriaceae throughout Europe and collected comparable data.
How oxygen radicals can protect against severe malaria
Scientists from the Heidelberg University Hospital and the German Center for Infection Research (DZIF) have succeeded in elucidating and specifically activating protective mechanisms against malaria.
17 January 2017 - PRESS RELEASE
A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans. The results of the trial have just been published in Nature Medicine. [ more ]
30 November 2016 - PRESS RELEASE
28 November 2016 - PRESS RELEASE
DZIF e. V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL email@example.com